Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39994567

about

A granulin-like growth factor secreted by the carcinogenic liver fluke, Opisthorchis viverrini, promotes proliferation of host cells Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling Carcinogenic Parasite Secretes Growth Factor That Accelerates Wound Healing and Potentially Promotes Neoplasia Expression of the growth factor progranulin in endothelial cells influences growth and development of blood vessels: a novel mouse model A shift to organismal stress resistance in programmed cell death mutants Infection with the carcinogenic human liver fluke, Opisthorchis viverrini Granulin-epithelin precursor is an oncofetal protein defining hepatic cancer stem cells Targeted manipulation of the sortilin-progranulin axis rescues progranulin haploinsufficiency The Evolution of the Secreted Regulatory Protein Progranulin Identification and characterization of tropomyosin 3 associated with granulin-epithelin precursor in human hepatocellular carcinoma A new procedure for determining the genetic basis of a physiological process in a non-model species, illustrated by cold induced angiogenesis in the carp MiR-145 mediates zebrafish hepatic outgrowth through progranulin A signaling.Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study.Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo Progranulin A-mediated MET signaling is essential for liver morphogenesis in zebrafish.Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice Suppression of Ov-grn-1 encoding granulin of Opisthorchis viverrini inhibits proliferation of biliary epithelial cells.Progranulin is a novel independent predictor of disease progression and overall survival in chronic lymphocytic leukemia.Progranulin: a promising therapeutic target for rheumatoid arthritis.Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.The role of PGRN in musculoskeletal development and disease.Waking up dormant tumors Progranulin: a growth factor, a novel TNFR ligand and a drug target 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.Prevention of LPS-induced acute lung injury in mice by progranulin Onco-proteogenomics identifies urinary S100A9 and GRN as potential combinatorial biomarkers for early diagnosis of hepatocellular carcinoma.Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.New tools for functional genomic analysis.Growth factors as active participants in carcinogenesis: a perspective.Role of progranulin as a biomarker for Alzheimer's disease.Biology of hepatic cancer stem cells.Cellular effects of progranulin in health and disease.Structure, function, and mechanism of progranulin; the brain and beyond.Screening of liver-targeted drugs.Progranulin: a novel regulator of gastrointestinal cancer progression.Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line.

P2860

Q21131573-5AE6C3E5-3B6E-497A-95B8-1B92E9AFD401 Q21133890-62243637-BD7B-4406-8ABA-2736AFB45318 Q27317022-646468F2-CAF1-46E3-86FF-E61FB589B2C7 Q27317909-8BCA2D73-6D1D-442D-A5C5-C6A3B823D676 Q27320732-3579C411-886D-4738-B64D-42E5592D5063 Q27692556-941CFDB3-F6AE-45CB-9570-7ADE74929210 Q28478455-FDBD8932-94A4-4E07-A2DB-F45B8EC9F43A Q28587955-D517A4B8-71E7-4156-96F8-D585C4B0ED64 Q28642185-51D791FB-0501-4969-A4F4-DA0FABF364F7 Q28727430-687908F2-5CAF-4BD9-8381-7AC2BFC59E61 Q33512121-FB0D2B67-AEA1-49D4-8E2A-4E4192D274D9 Q33713078-A20C0480-33E6-4B86-9FCA-ECA278D7A9FD Q33785050-BAAC20CD-7F39-4413-9920-02AF2AC95909 Q34326604-B59B1D0B-57B3-4918-8319-21827B04F41D Q34402163-4C005FC5-83CC-4C2C-BE53-53D7CDBC0D58 Q34412775-A32EC607-30E3-4FF6-A19C-F6DF54705495 Q34519881-D5A166BE-CF98-438C-A72C-3D03C9A9BA56 Q34778995-EBEC4F40-BFE5-4245-93FF-765111D487EA Q34979505-574F58B2-9F48-4098-8833-2AB9ED0A3017 Q35182029-E7795191-5BC6-4C18-8519-AE9240E35205 Q35491733-14B5163F-F65C-403E-8097-8C1762D9C36B Q35546476-4F402AD0-76A7-4420-84CC-56DE47E23B5B Q35558013-FDA3F05F-C3B0-4A7D-AAB3-B1AEEAC6DBC3 Q35601050-7E88BE08-161C-4CFF-A2A7-1400C8FA7672 Q35602416-3092FE08-6D98-4ABA-AF3E-1F88F66D679B Q35623336-B857C080-25DE-4E80-A36C-CF3B3CFFE0FF Q35841978-3E225FE9-D922-479B-B804-990CAE006872 Q36118028-0F5D5188-360B-4D3C-8A3C-6CBFCF2B7815 Q36200118-E152B01D-824A-4F6E-BE2F-7D4F9FBBF4FA Q36347633-C7550EDF-905B-408C-A113-8AE72D75D73B Q37457751-A5316385-AD0D-4118-8079-C58191C860C9 Q37499291-3C6E4288-FF03-42A1-B6D2-2BE3180281DF Q37676697-85C7E451-971D-40A1-B128-BDE694CF11DD Q37730008-08EE3D07-A92E-476C-95C3-4359AC125810 Q37873961-94206D5F-06AA-4070-892E-ED231825209F Q37879596-A35200BD-FA88-42F4-A4A7-0ECC995212FB Q37892442-31F56D78-768B-4318-A176-3D48DC9D5733 Q38090671-C17424F5-608C-4DA5-827B-36464582E269 Q38138097-DC1003B6-8CFF-43B2-A81E-A5DF637A9E8E Q38765553-A4CEF580-60E6-4B04-AB1B-CF8BC23EB558

P2860

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q39994567

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

@en

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

@nl

type

label

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

@en

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

@nl

prefLabel

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

@en

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma.

@nl

P1433

Q39994567-4A3688DC-E1EB-4E70-9482-8089AD017C70

P1476

Q39994567-D798D6F5-3C15-4C88-95BC-AB89CDECD1FF

P2093

Q39994567-3E1CD36C-E2BB-491D-8EE7-1C834547B099

Q39994567-3E4B9C27-5432-420E-8EA3-F38192228C20

Q39994567-5C35612D-EFD8-4784-BDDD-B8A1A682DD89

Q39994567-990D192D-4DB7-482E-96EF-FCD8B38FC6A0

Q39994567-B22F4027-3DED-4859-BB5E-8CE726E5DA6F

Q39994567-F3530CA3-DDA6-4ED6-AD05-62518F4EAA1C

P2860

Q39994567-023F378F-349F-4691-BBCE-A714E52CDC45

Q39994567-092BDE2B-72EE-497F-BB91-F41BF2F46D82

Q39994567-1261709C-7359-4C6B-B6E3-6A61E972247F

Q39994567-1D21DDFC-3D91-487C-9C97-00505145EE03

Q39994567-1F4C3AB4-7840-4BC9-86A5-7FB33E4BA0E3

Q39994567-20E57525-8F5C-486F-9FC1-6535BFB0B88C

Q39994567-272FCE8D-3184-4A2B-8DDB-90B156E36F2E

Q39994567-319D1E34-BEE7-4A6F-9B6D-FD28657855A3

Q39994567-31B943B1-8F02-4677-AEEB-5D26E17ADCDC

Q39994567-3A665CF1-1608-4C55-B5BE-76E742793554

P304

Q39994567-7798EE18-64B6-4008-8001-372B4103A436

P31

Q39994567-EF80B28A-F363-4609-B488-07452DFC9CAB

P356

Q39994567-D289EE01-6480-4E04-8ECD-99B3E5478F8E

P407

Q39994567-83CA050E-AAD9-4F47-894D-3FC2A15DF84F

P433

Q39994567-DF016B13-B0DB-497F-9A0E-1AEADE742D62

P478

Q39994567-D79CF4D5-2769-409A-8BA2-74DF2EF4499C

P50

Q39994567-8FF76808-945D-4C88-B10C-6AFD59729CE8

P577

Q39994567-7486970A-3470-4527-9956-01C182878EAD

P5875

Q39994567-00C83BCA-1BE0-40EC-925B-EFC3E2C99788

P698

Q39994567-3AF397EA-3D25-4698-B8D1-191AC15D28CC

P356

P1433

P1476

Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma

@en

P2093

Jenny C Ho

http://www.w3.org/2001/XMLSchema#string

Kui Fat Chan

http://www.w3.org/2001/XMLSchema#string

San Yu Wong

http://www.w3.org/2001/XMLSchema#string

Sheung Tat Fan

http://www.w3.org/2001/XMLSchema#string

Ying Chi Ip

http://www.w3.org/2001/XMLSchema#string

Yuk Ting Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study.

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

Gene expression patterns in human liver cancers.

Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma.

Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy

Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis.

Novel approaches for targeted cancer therapy.

Hepatocellular carcinoma: recent trends in the United States.

Gene expression microarray technologies in the development of new therapeutic agents.

P304

1524-1532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22191

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5460009

http://www.w3.org/2001/XMLSchema#string

P698

18393387

http://www.w3.org/2001/XMLSchema#string